Yitzhak Peterburg

Yitzhak Peterburg is currently a Director at Regenera Pharma Ltd. He previously held positions such as President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd. in 2017, President & Chief Executive Officer at Cellcom Israel Ltd. in 2005, Chief Executive Officer at Clalit Health Services from 1997 to 2002, Chief Executive Officer at Soroka University Medical Center from 1995 to 1997, Chairman at EndyMed Ltd. from 2007 to 2010, and Director at Teva Pharmaceutical Industries Ltd. in 2010.
He also served as a Director at Rosetta Genomics Ltd. from 2012 to 2015 and as a Non-Executive Director at CritiSense Ltd. He was a Professor at Ben-Gurion University of the Negev from 2000 to 2012.
Dr. Peterburg holds a doctorate degree from The Trustees of Columbia University in The City of New York in 1987, a graduate degree from the London School of Economics & Political Science in 1990, a doctorate degree from Joseph L.
Mailman School of Public Health, and a doctorate degree from The Hebrew University Hadassah Medical School in 1977.